StonvexLoading…
StonvexStonvexStonvexCore line items from EBF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Annual 2025 2025-02-28 | Annual 2024 2024-02-29 | Annual 2023 2023-02-28 |
|---|---|---|---|---|
Revenue | $392.40M | $394.62M | $420.11M | $431.84M |
Operating Income | $52.69M | $51.97M | $56.46M | $66.15M |
Net Income | $42.63M | $40.22M | $42.60M | $47.30M |
EPS (Diluted) | $1.66 | $1.54 | $1.64 | $1.82 |
Total Assets | $356.91M | $348.94M | $399.19M | $393.83M |
Total Liabilities | $48.18M | $46.95M | $49.35M | $62.40M |
Cash & Equivalents | $34.57M | $67.00M | $81.60M | $93.97M |
Free Cash Flow OCF − CapEx | $41.03M | $59.97M | $62.57M | $42.44M |
Shares Outstanding | 25.69M | 30.05M | 30.05M | 25.95M |